Published in Br J Cancer on May 04, 2004
Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg (2010) 1.95
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
Risk factors and outcomes for anastomotic leakage in colorectal surgery: a single-institution analysis of 1576 patients. World J Surg (2011) 1.66
Markers of systemic inflammation predict survival in patients with advanced renal cell cancer. Br J Cancer (2013) 1.60
The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder. Br J Cancer (2005) 1.24
The relationship between the preoperative systemic inflammatory response and cancer-specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer (2006) 1.07
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Prognostic significance of pre-operative C-reactive protein and the neutrophil-lymphocyte ratio in resectable pancreatic cancer: a systematic review. HPB (Oxford) (2014) 0.89
Evaluation of an inflammation-based prognostic score for the identification of patients requiring postoperative adjuvant chemotherapy for stage II colorectal cancer. Exp Ther Med (2010) 0.86
The effect of obstruction and perforation on colorectal cancer disease-free survival. World J Surg (2010) 0.83
Prognostic significance of C-reactive protein in patients with intermediate-risk metastatic renal cell carcinoma treated with molecular targeted therapy. Oncol Lett (2014) 0.82
External validation of the modified Glasgow prognostic score for renal cancer. Indian J Urol (2014) 0.81
The relationship between patient physiology and cancer-specific survival following curative resection of colorectal cancer. Br J Cancer (2007) 0.77
Social network ties and inflammation in U.S. adults with cancer. Biodemography Soc Biol (2014) 0.75
Inflammation and cancer. Nature (2002) 53.78
The spread of rectal cancer and its effect on prognosis. Br J Cancer (1958) 10.06
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer (2000) 2.50
Acute-phase protein response, survival and tumour recurrence in patients with colorectal cancer. Br J Surg (2001) 1.96
Significance of preoperative elevation of serum C-reactive protein as an indicator for prognosis in colorectal cancer. Am J Surg (1998) 1.88
Stimulation of tumour growth by wound-derived growth factors. Br J Cancer (1999) 1.80
Preoperative plasma plasminogen activator inhibitor type-1 and serum C-reactive protein levels in patients with colorectal cancer. The RANX05 Colorectal Cancer Study Group. Ann Surg Oncol (2000) 1.58
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg (1995) 1.32
Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg (2003) 1.26
Serum C-reactive protein correlates with survival in colorectal cancer patients but is not an independent prognostic indicator. Eur J Gastroenterol Hepatol (2003) 1.22
Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg (2003) 6.04
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Psychological support for patients undergoing breast cancer surgery: a randomised study. BMJ (1996) 4.11
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer (2003) 3.44
The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small cell lung cancer. Br J Cancer (2002) 2.80
Effect of the inflammatory response on trace element and vitamin status. Ann Clin Biochem (2000) 2.79
Randomised controlled trial of conservation therapy for breast cancer: 6-year analysis of the Scottish trial. Scottish Cancer Trials Breast Group. Lancet (1996) 2.78
Prognostic factors in advanced gastrointestinal cancer patients with weight loss. Nutr Cancer (2000) 2.50
Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J Am Coll Surg (2000) 2.48
Impact of anastomotic leakage on long-term survival of patients undergoing curative resection for colorectal cancer. Br J Surg (2005) 2.45
Management of the malignant colorectal polyp: ACPGBI position statement. Colorectal Dis (2013) 2.41
A derived neutrophil to lymphocyte ratio predicts survival in patients with cancer. Br J Cancer (2012) 2.41
Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer. Br J Cancer (2004) 2.39
Evaluation of an inflammation-based prognostic score in patients with inoperable gastro-oesophageal cancer. Br J Cancer (2006) 2.33
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study. Br J Cancer (2011) 2.21
Is the landmark technique safe for the insertion of subclavian venous lines? Surgeon (2005) 2.17
Incidence of nausea and vomiting with cytotoxic chemotherapy: a prospective randomised trial of antiemetics. Br Med J (1979) 2.15
Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss. Nutr Cancer (2001) 2.10
Proceedings: Comparison of a coronary vasodilator drug (carbochromen) and a cardiac stimulant (oxyfedrin) on blood flow and oxygen extraction in experimental myocardial infarcts. Br J Pharmacol (1972) 1.94
Occult hepatic metastases in colorectal carcinoma. Br J Surg (1986) 1.90
Longitudinal study of body cell mass depletion and the inflammatory response in cancer patients. Nutr Cancer (1998) 1.88
Long-term clinical outcome of surgery for solitary rectal ulcer syndrome. Br J Surg (1998) 1.80
Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer (2001) 1.80
Still hungry in hospital: identifying malnutrition in acute hospital admissions. QJM (2000) 1.75
An elevated C-reactive protein concentration, prior to surgery, predicts poor cancer-specific survival in patients undergoing resection for gastro-oesophageal cancer. Br J Cancer (2006) 1.75
Metabolic response to feeding in weight-losing pancreatic cancer patients and its modulation by a fish-oil-enriched nutritional supplement. Clin Sci (Lond) (2000) 1.74
The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br J Cancer (2010) 1.73
An evaluation of the impact of a multidisciplinary team, in a single centre, on treatment and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.71
Systemic inflammatory response predicts outcome in patients undergoing resection for ductal adenocarcinoma head of pancreas. Br J Cancer (2005) 1.71
Surgery for occult rectal prolapse. Colorectal Dis (2004) 1.70
The relationship between tumour T-lymphocyte infiltration, the systemic inflammatory response and survival in patients undergoing curative resection for colorectal cancer. Br J Cancer (2005) 1.69
Preoperative but not postoperative systemic inflammatory response correlates with survival in colorectal cancer. Br J Surg (2007) 1.62
Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy. Lancet (2000) 1.58
The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. Br J Cancer (2003) 1.58
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer. Br J Cancer (1996) 1.57
Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer. Br J Cancer (2007) 1.57
Growth rate of hepatic metastases in colorectal carcinoma. Br J Surg (1988) 1.55
Free radical activity and lipid soluble anti-oxidant vitamin status in patients with long-term ileal pouch-anal anastomosis. Colorectal Dis (2008) 1.53
Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J (Clin Res Ed) (1986) 1.51
Surgeons and selection of adjuvant therapy for node-negative colonic cancer. Br J Surg (2010) 1.49
Vitamin B12 deficiency following restorative proctocolectomy. Colorectal Dis (2007) 1.49
Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer (2006) 1.48
Transcutaneous electrical stimulation for postoperative pain. Ann R Coll Surg Engl (1985) 1.48
Strategy for the surgical management of patients with idiopathic megarectum and megacolon. Br J Surg (2001) 1.48
Transient femoral nerve palsy complicating preoperative ilioinguinal nerve blockade for inguinal herniorrhaphy. Br J Surg (1994) 1.48
A prospective longitudinal study of performance status, an inflammation-based score (GPS) and survival in patients with inoperable non-small-cell lung cancer. Br J Cancer (2005) 1.46
Longitudinal study of weight, appetite, performance status, and inflammation in advanced gastrointestinal cancer. Nutr Cancer (1999) 1.45
Detection of colorectal liver metastases: comparison of laparotomy, CT, US, and Doppler perfusion index and evaluation of postoperative follow-up results. Radiology (1995) 1.45
Comparison of visual and automated assessment of Ki-67 proliferative activity and their impact on outcome in primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer. Br J Cancer (2012) 1.44
The morphine sparing effect of ketorolac tromethamine. A study of a new, parenteral non-steroidal anti-inflammatory agent after abdominal surgery. Anaesthesia (1987) 1.44
Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival. Cancer J Sci Am (2006) 1.43
Target-controlled infusions of propofol and remifentanil with closed-loop anaesthesia for hepatic resection. Anaesthesia (2002) 1.40
Colonic motility is abnormal before surgery for rectal prolapse. Br J Surg (1999) 1.40
The relationship between intraoperative contamination of the lower respiratory tract and postoperative chest infection. J Hosp Infect (1995) 1.40
Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg (2002) 1.39
Ketorolac trometamol for postoperative analgesia after orthopaedic surgery. Br J Anaesth (1992) 1.38
Elevated circulating interleukin-6 is associated with an acute-phase response but reduced fixed hepatic protein synthesis in patients with cancer. Ann Surg (1991) 1.36
The value of routine preoperative investigations. Ann R Coll Surg Engl (1987) 1.35
Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer (2009) 1.35
Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer. Br J Surg (2011) 1.33
A prospective study of tumor recurrence and the acute-phase response after apparently curative colorectal cancer surgery. Am J Surg (1995) 1.32
Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut (1993) 1.31
Incidence and detection of occult hepatic metastases in colorectal carcinoma. Br Med J (Clin Res Ed) (1982) 1.31
The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer. Br J Cancer (2012) 1.31
Impact of weight loss, appetite, and the inflammatory response on quality of life in gastrointestinal cancer patients. Nutr Cancer (1998) 1.31
The role of the in situ local inflammatory response in predicting recurrence and survival in patients with primary operable colorectal cancer. Cancer Treat Rev (2011) 1.29
Prospective study of the treatment of septic shock. Lancet (1978) 1.27
The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer (2004) 1.27
The use of duplex sonography in the detection of colorectal hepatic metastases. Br J Cancer (1991) 1.27
Male gender adversely affects survival following surgery for colorectal cancer. Br J Surg (2003) 1.26